Stock Quote        
  Join        Login  
logo

Analyst Comments: Qiagen, Virgin Media, Priceline, NovaMed

 August 07, 2008 02:57 PM
 

Qiagen Spending for Growth

Qiagen N.V. (QGEN), through its subsidiaries in Europe, Asia, Australia, Canada, and the U.S., operates in the life sciences industry with a portfolio of more than 500 products and automated solutions. Though the molecular diagnostic and research market offer enormous growth, the company faces stiff competition. As such, we maintain our Hold rating for Qiagen.

The company continues to remain aggressive on the acquisition front. The most significant deal closed by the company in July 2007, is the acquisition of Digene Corp., which should boost the topline going forward. Another recent significant acquisition was Corbett Life Sciences which occurred in July 2008.

We believe the company will continue entering into strategic partnerships and alliances going forward. We are optimistic on a number of new research products and potential breakthrough procedures for fractionation of proteins using Qiagen's new product offerings.

We would, however, like to see more home-brew protocols begin to use Qiagen's products and trends in research spending stabilize before we become bullish on the company. Our $22 price target corresponds to 35 x our projected fiscal 2009 EPS of $0.75, discounted back at 20 percent for one year. We believe that Qiagen shares offer only limited upside at the current price.

Virgin Media in Early Turnaround

Virgin Media, Inc. (VMED) is in the early stages of a turnaround, poised to generate strong free cash flow growth and improved EPS in 2009. A new management team is re-branding the services and rolling out digital services to stabilize average revenue per user (ARPU), reduce churn and slow its market share drain from the onslaught of new entrants into VMED's markets.

The company remained focused on leading in next generation broadband and redefining the TV experience through video on demand (VOD). On the cost side, we expect lower interest expense, capital expenditures and income taxes to increase free cash flow beginning this year. The stock is currently trading at a steep discount to chief competitor BSkyB and its other cable peers, a discount that we think will narrow as profitability improves, or as management gets closer to selling the company.

First quarter 2008 results reflected the nascent turnaround, with growth in net subscribers and revenue-generating users. The company added 4,900 net subscribers in 1Q08 compared to 46,900 net disconnections in 1Q07.

In order to compete with rival BSkyB on broadband is launching superfast broadband speeds to woo customers. In broadband, the company is better placed to compete as it already offers speeds of up to 20 megabits per second to some customers, and has successfully trialed 50 megabits with a view to offer content such as high definition programming on demand.


Next Page >>12

Rich
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.

You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.

Two Week FREE Trial


Signup for i on the market daily edition


Advertisement

Comments Closed


Author: Zacks Investment Research
Zacks Investment Research

Advertisement
Connect with iStockAnalyst
Popular Articles
Recent Research and Quote
Advertisement
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.